Your request to link to rcsb for Fibroblast growth factor receptor 3

---

• 1GJO: the fgfr2 tyrosine kinase domain
• 1OEC: fgfr2 kinase domain
• 1RY7: crystal structure of the 3 ig form of fgfr3c in complex with fgf1 (10.1073/PNAS.0307287101 )
• 2PVF: crystal structure of tyrosine phosphorylated activated fgf receptor 2 (fgfr2) kinase domain in complex with atp analog and substrate peptide (10.1016/J.MOLCEL.2007.06.028 )
• 2PVY: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic k659n mutation responsible for an unclassified craniosynostosis syndrome. 21-dec-16 2pvy 1 title (10.1016/J.MOLCEL.2007.06.028 )
• 2PWL: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic n549h mutation responsible for crouzon syndrome. 21-dec-16 2pwl 1 title (10.1016/J.MOLCEL.2007.06.028 )
• 2PY3: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic e565g mutation responsible for pfeiffer syndrome 21-dec-16 2py3 1 title (10.1016/J.MOLCEL.2007.06.028 )
• 2PZ5: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic n549t mutation responsible for pfeiffer syndrome 21-dec-16 2pz5 1 title (10.1016/J.MOLCEL.2007.06.028 )
• 2PZP: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic k526e mutation responsible for crouzon syndrome 21-dec-16 2pzp 1 title (10.1016/J.MOLCEL.2007.06.028 )
• 2PZR: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic k641r mutation responsible for pfeiffer syndrome 21-dec-16 2pzr 1 title (10.1016/J.MOLCEL.2007.06.028 )
• 2Q0B: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic e565a mutation responsible for pfeiffer syndrome 21-dec-16 2q0b 1 title (10.1016/J.MOLCEL.2007.06.028 )
• 3B2T: structure of phosphotransferase (10.1073/PNAS.0709905104 )
• 3CLY: crystal structure of fgf receptor 2 (fgfr2) kinase domains trapped in trans-phosphorylation reaction (10.1073/PNAS.0807752105 )
• 3GRW: fgfr3 in complex with a fab (10.1172/JCI38017 )
• 3RI1: crystal structure of the catalytic domain of fgfr2 kinase in complex with arq 069 (10.1074/JBC.M110.213736 )
• 4J95: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic k659n mutation responsible for an unclassified craniosynostosis syndrome in space group c2. 28-dec-16 4j95 1 title (10.1016/J.CELREP.2013.06.025 )
• 4J96: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic gain-of-function k659m mutation identified in cervical cancer. 28-dec-16 4j96 1 title (10.1016/J.CELREP.2013.06.025 )
• 4J97: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic gain-of-function k659e mutation identified in endometrial cancer. 28-dec-16 4j97 1 title (10.1016/J.CELREP.2013.06.025 )
• 4J98: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the gain-of-function k659q mutation. 28-dec-16 4j98 1 title (10.1016/J.CELREP.2013.06.025 )
• 4J99: crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the gain-of-function k659t mutation. 28-dec-16 4j99 1 title (10.1016/J.CELREP.2013.06.025 )
• 4K33: crystal structure of fgf receptor 3 (fgfr3) kinase domain harboring the k650e mutation, a gain-of-function mutation responsible for thanatophoric dysplasia type ii and spermatocytic seminoma 28-dec-16 4k33 1 title (10.1016/J.STR.2013.07.017 )
• 5UGL: crystal structure of fgf receptor 2 tyrosine kinase domain harboring the d650v activating mutation (10.7554/ELIFE.21137 )
• 6AGX: the cocrystal structure of fgfr2 bound with compound 14 harboring 5h- pyrrolo[2,3-b]pyrazine scaffold
• 6LVK: crystal structure of fgfr2 in complex with 1,3,5-triazine derivative (10.1016/J.BMC.2020.115453 )
• 6LVL: crystal structure of fgfr2 in complex with 1,3,5-triazine derivative (10.1016/J.BMC.2020.115453 )
• 6LVM: crystal structure of fgfr3 in complex with pyrimidine derivative (10.1016/J.BMC.2020.115453 )
• 6PNX: crystal structure of an asymmetric dimer of fgf receptor 3 kinases trapped in a-loop tyrosine transphosphorylation reaction (10.1038/S41589-019-0455-7 )
• 7DHL: crystal structure of fgfr3 in complex with pyrimidine derivative (10.1016/J.BMC.2021.116019 )
• 7KIA: crystal structure of fgfr2 kinase domain gatekeeper mutant v564f in complex with covalent compound 19 (10.1021/ACSMEDCHEMLETT.0C00517 )
• 7KIE: crystal structure of fgfr2 kinase domain gatekeeper mutant v564f in complex with covalent compound 3 (10.1021/ACSMEDCHEMLETT.0C00517 )